Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany

Cronos Group Inc. (“Cronos”), a publicly traded global cannabis company, and Cansativa GmbH ("Cansativa"), the German market leader for medical cannabis, have entered into a supply agreement for the import, marketing, and distribution of the PEACE NATURALS® product line in Germany. The first of three products will be delivered to pharmacies on 1st of November 2023. Two further products will launch by November 2023. Pre-orders via the online shop of Cansativa are available for pharmacies now.

The PEACE NATURALS® brand is returning to the German market after a brief absence. While it was available sporadically, Cansativa and Cronos have the shared goal to keep the brand and its products available in Germany over the long term.

The PEACE NATURALS® product range that will be available in Germany initially includes three cannabis dried flower varieties: GMO Cookies, Cocoa Bomba and Space Cake. In the Canadian cannabis market, Cronos has won awards for its products and innovations in a number of product categories. Cronos has invested heavily in research and development for its genetic breeding and tissue culture program, which have resulted in cultivars medical patients can count on for quality and consistency. Cronos has a sophisticated flower genetics and cultivar program, headed by industry-leading R&D professionals who have brough best-selling strains to consumers in medical and adult-use markets.

Patients can obtain relevant information, including THC levels and cannabinoid specifics ofPEACE NATURALS® products, from their physician, local pharmacy or a Cansativa partner pharmacy.

"We are very happy to bring such a successful brand like PEACE NATURALS® back to Germany," says Benedikt Sons, founder and CEO of Cansativa. "Together with our partner Cronos, we want to ensure a reliable and consistent supply of these high-quality products for cannabis patients."

"We intend to establish our PEACE NATURALS® brand as a top medical brand in Germany," says Mike Gorenstein, Chairman and CEO of Cronos. "We are proud to bring high-quality, medical cannabis to this market and look forward to establishing PEACE NATURALS® as a trusted brand in Germany."

About Cansativa Group

Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medicinal cannabis market. Since the award of the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, it is the only company with approval for the distribution of medicinal cannabis from German cultivation. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medicinal cannabis in the context of pain therapies.

With regard to the planned legalisation of cannabis, the Cansativa Group sees itself as a pioneer in the democratisation of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute and brand cannabis. The company is also committed to cannabis education. With the vision "We enable Cannabis", Cansativa sees itself as a driving force of the cannabis industry in Germany.

Further information www.cansativa-group.de

About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about importing, distributing and marketing the PEACE NATURALS® product line; anticipated delivery and launch dates of such products; the availability of the PEACE NATURALS® product line in Germany and the consistency and reliability of the supply thereof; the quality and consistency of Cronos cultivars; the PEACE NATURALS® brand and its positioning in Germany; Cansativa’s impact on the cannabis industry in Germany; and the Cronos brand portfolio. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results and performance or achievements expressed or implied by those Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, each of which has been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Press contacts:

Cansativa Group
Ioana Freise, External Affairs
pr@cansativa.de

Cronos Group
Emily Whalen, Media Relations
media.relations@thecronosgroup.com